Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle
about
Pharmacotherapy for the management of achalasia: Current status, challenges and future directionsIGF-1 antibody prolongs the effective duration time of botulinum toxin in decreasing muscle strengthChallenges in searching for therapeutics against Botulinum Neurotoxins.Acrylamide inhibits nerve sprouting induced by botulinum toxin type A.Botulinum Toxin Induced Atrophy: An Uncharted Territory
P2860
Modulating neuromuscular junction density changes in botulinum toxin-treated orbicularis oculi muscle
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@ast
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@en
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@nl
type
label
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@ast
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@en
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@nl
prefLabel
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@ast
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@en
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@nl
P2093
P2860
P356
P1476
Modulating neuromuscular junct ...... eated orbicularis oculi muscle
@en
P2093
Andrew R Harrison
Brian C Anderson
Linda K McLoon
Michael S Lee
Mollie Semmer
Renzo A Zaldivar
Zachary Berbos
P2860
P304
P356
10.1167/IOVS.10-6427
P407
P577
2011-02-23T00:00:00Z